Furthermore, blockade of the IL-10 receptor has been shown to reverse the pathogenic effects of IL-10 in vivo, indicating that inhibiting IL-10 signaling may offer a potential therapeutic strategy for treating GVHD [159]. This evidence concerns the gene IL10 and graft versus host disease.